Veille Scientifique

Patrice PIENKOWSKI
Coordinateur

 Après 3 ans de bons et loyaux services, la veille scientifique va s’arrêter ; voici les derniers articles sélectionnés à votre intention.
 
Nous avons pris cette décision difficile suite au constat d’un investissement très important pour un service rendu finalement incertain, comme l’attestent les statistiques de fréquentation de la rubrique sur ce site. 
 
Je remercie tous ceux et celles qui se sont investis dans la durée pour assurer la réussite du projet, à commencer par les responsables des groupes de veille : Emmanuel Coron (Endoscopie), Roger Faroux (Cancérologie), Pauline Jouët (Gastro-entérologie et proctologie), Stéphane Nahon (MICI), Vinciane Rebours (Pancréatologoie) et Christine Silvain (Hépatologie), mais aussi et surtout, tous les veilleurs anonymes pour la grande qualité de leur travail, leur compétence et leur persévérance.
Le travail de veille bibliographique ne disparait pas complètement malgré tout, grâce aux GastroScoops dont la fréquence va augmenter avec un objectif de diffusion hebdomadaire ; il s’agit d’un travail rédactionnel différent avec une analyse d’article plus approfondie et structurée, porteur de message important.

Restez donc fidèles à ces rubriques et visitez régulièrement le site de la SNFGE toujours très riche d’enseignements et d’informations.

Très cordialement.

Dr Patrice PIENKOWSKI

 

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie

Foie/
VB/
Addicto

Gastro/
Procto/

Nutrition
MICI Pancréas
R. FAROUX E. CORON C. SILVAIN P. JOUET S. NAHON V. REBOURS

T. APARICIO
A. LOPEZ
S. MANFREDI
Y. TOUCHEFEU

A. CULETTO
Y. LEBALEUR
G. PERROD
V. VALANTIN

C. BARRAULT
P. DUKAN
N. GANNE-CARRIE
JL. PAYEN
PE. RAUTOU
D. VALLA

H. DAMON
F. CORDET
T. HIGUERO
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
M. FUMERY
D LAHARIE
P. SEKSIK

M. CAMUS-DUBOC
E. GELSI
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revuetrier par ordre décroissant Titre Date Coup de coeur Thématique
Inflammatory Bowel Diseases Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies aoû. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Outcomes of Endoscopic Balloon Dilation vs Surgical Resection for Primary Ileocolic Strictures in Patients With Crohn's Disease. aoû. 18 3 ♥ Endoscopie/Imagerie
Clinical Gastroenterology and Hepatology Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases fév. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Surgical Interventions and the Use of Device-Aided Therapy for the Treatment of Fecal Incontinence and Defecatory Disorders. déc. 17 4 ♥ Coloproctologie
Clinical Gastroenterology and Hepatology Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis. avr. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled Trials déc. 15 3 ♥ MICI
Clinical Gastroenterology and Hepatology Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases. avr. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. mar. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study. juil. 17 2 ♥ Pancréas/Voies biliaires
Clinical Gastroenterology and Hepatology Characteristics and Progression of Preclinical Inflammatory Bowel Disease. sep. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Risk of Rectal Cancer After Colectomy for Patients With Ulcerative Colitis: A National Cohort Study juil. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Biologics Delay Progression of Crohn’s Disease, but Not Early Surgery, in Children sep. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide sep. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort Studies Jan. 19 4 ♥ Pancréas/Voies biliaires
Clinical Gastroenterology and Hepatology Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease. mar. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. juin. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis juil. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology High Prevalence of Anal Canal High-Risk Human Papillomavirus Infection in Patients With Crohn's Disease. nov. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Surgical Interventions and the Use of Device-Aided Therapy for the Treatment of Fecal Incontinence and Defecatory Disorders. déc. 17 4 ♥ Colo-proctologie
Clinical Gastroenterology and Hepatology Chromoendoscopy Is More Effective Than Standard Colonoscopy in Detecting Dysplasia During Long-term Surveillance of Patients With Colitis. mai. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis. sep. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Disease mai. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases juil. 16 3 ♥ MICI, Cancer colorectal (CCR)
Clinical Gastroenterology and Hepatology Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases. mar. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis. mai. 17 3 ♥ MICI

Pages